PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer

被引:0
|
作者
Ambrosini, Francesca [1 ,2 ]
Koehler, Daniel [3 ]
Ghadban, Tarik [4 ]
Jacobsen, Frank [5 ]
Knipper, Sophie [1 ]
von Amsberg, Gunhild [1 ,6 ]
Steuber, Thomas [1 ,7 ]
Maurer, Tobias [1 ,7 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, 52 Martinistr, D-20246 Hamburg, Germany
[2] IRCCS Osped Policlin San Martino, Genoa, Italy
[3] Univ Hosp Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany
[4] Univ Hosp Hamburg Eppendorf, Dept Surg, Hamburg, Germany
[5] Univ Hosp Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[6] Univ Hosp Hamburg Eppendorf, Dept Oncol, Hamburg, Germany
[7] Univ Hosp Hamburg Eppendorf, Dept Urol, Hamburg, Germany
关键词
prostate cancer; prostate-specific membrane antigen; liver; radioguided surgery;
D O I
10.5173/ceju.2023.69
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We present the case of a patient who underwent an open radical prostatectomy with pelvic lymph node dissection (Gleason 4+3, pT3a pN1 R0) in March 2017. In November 2020, prostate-specific membrane antigen (PSMA) -radioguided salvage lymph node dissection was planned due to a single left para-rectal lymph node at a [68Ga] Ga-PSMA-I&T PET. In January 2022, the [68Ga] Ga-PSMA-I&T PET showed an isolated liver lesion. Biopsy confirmed prostate adenocarcinoma. A liver segmentectomy was performed. A complete biochemical response was reported until the last follow-up (December 2022). Prostate-specific membrane antigen positron emission tomography (PSMA PET)-directed metastasis-directed therapy may be an effective treatment in selected cases, allowing a benefit in the oncological outcome.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 50 条
  • [41] Individual Patient Level Meta-Analysis of Prospective Trials Studying Metastasis-Directed Therapy for Metachronous Oligometastatic Prostate Cancer
    Tran, P. T.
    Berlin, A.
    Siva, S.
    Reynders, D.
    Phillips, R.
    Glicksman, R.
    Foroudi, F.
    Udovicich, C.
    Fonteyne, V.
    Deek, M. P.
    Feng, F. Y.
    Chung, P.
    Murphy, D.
    Ost, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E295 - E296
  • [42] Metastasis-directed treatment in kidney cancer
    Jackson, Jamaal C.
    Franco, Antonio
    Wang, Dian
    Autorino, Riccardo
    Vourganti, Srinivas
    CURRENT OPINION IN UROLOGY, 2023, 33 (05) : 375 - 382
  • [43] The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
    Kim, Jongchan
    Park, Jee Soo
    Ham, Won Sik
    INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (05) : 307 - 316
  • [44] Metastasis-directed therapy for oligometastasis and beyond
    Thomas H. Beckham
    T. Jonathan Yang
    Daniel Gomez
    C. Jillian Tsai
    British Journal of Cancer, 2021, 124 : 136 - 141
  • [45] Metastasis-directed therapy for oligometastasis and beyond
    Beckham, Thomas H.
    Yang, T. Jonathan
    Gomez, Daniel
    Tsai, C. Jillian
    BRITISH JOURNAL OF CANCER, 2021, 124 (01) : 136 - 141
  • [46] Metastasis-directed Therapy in solitary oligorecurrent Prostate Cancer without Androgen Deprivation Therapy - a Commentary
    Falkenbach, Fabian
    Maurer, Tobias
    UROLOGIE, 2023, 62 (04): : 404 - 406
  • [47] Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
    Ellen M. Cahill
    John L. Pfail
    Melinda Z. Fu
    Biren Saraiya
    Tina Mayer
    Ryan D. Stephenson
    Ronald D. Ennis
    Lara Hathout
    Matthew P. Deek
    Saum Ghodoussipour
    Thomas L. Jang
    Current Urology Reports, 2023, 24 : 299 - 306
  • [48] Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
    Cahill, Ellen M. M.
    Pfail, John L. L.
    Fu, Melinda Z. Z.
    Saraiya, Biren
    Mayer, Tina
    Stephenson, Ryan D. D.
    Ennis, Ronald D. D.
    Hathout, Lara
    Deek, Matthew P. P.
    Ghodoussipour, Saum
    Jang, Thomas L. L.
    CURRENT UROLOGY REPORTS, 2023, 24 (07) : 299 - 306
  • [49] Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging
    Carretero-Gonzalez, Alberto
    Kwon, Daniel
    Shakhnazaryan, Nonna
    Hong, Julian C.
    Mohamad, Osama
    Feng, Mary Uan-Sian
    de Kouchkovsky, Ivan
    Borno, Hala
    Bose, Rohit
    Chou, Jonathan
    Desai, Arpita
    Fong, Lawrence
    Friedlander, Terence W.
    Koshkin, Vadim S.
    Feng, Felix Y.
    Aggarwal, Rahul Raj
    Hope, Thomas A.
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
    Choi, Seo Hee
    Beom, Seung-Hoon
    Choi, Young Deuk
    Ham, Won Sik
    Han, Hyunho
    Han, Woong Kyu
    Jang, Won Sik
    Lee, Seung Hwan
    Cho, Jaeho
    CANCERS, 2024, 16 (18)